Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06409286 · ClinicalTrials.gov registry record
Assessment of Flow in Cerebrospinal Fluid Shunts With a Second Generation Wireless Thermal Anisotropy Measurement Device
A clinical trial, sponsored by Rhaeos.
- Not yet
- Registry status
- 17
- Enrollment target
NCT06409286 is a clinical trial that has not yet begun recruiting, run by Rhaeos. The registered enrollment target is 17 participants.
The verdict
NCT06409286 has not yet begun recruiting, sponsored by Rhaeos.
- NOT YET RECRUITING
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study evaluates the performance of a thermal anisotropy measurement device for non-invasively assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction who require shunt revision surgery will be evaluated with the study device to assess flow in CSF shunts as confirmed by surgical outcomes at 7 days. If successful, this study will show that the study device accurately distinguishes between functioning (flowing) and non-functioning (non-flowing) shunts.
Interventions
- DEVICE Thermal Anisotropy Measurement Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2025-07 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06409286
The ClinicalTrials.gov registry entry for NCT06409286 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thermal Anisotropy Measurement Device is the first listed.
NCT06409286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06409286 about?
NCT06409286 is a clinical study titled "Assessment of Flow in Cerebrospinal Fluid Shunts With a Second Generation Wireless Thermal Anisotropy Measurement Device". This study evaluates the performance of a thermal anisotropy measurement device for non-invasively assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction who require shunt revision surgery will be evaluated with the study device to assess flow in CSF sh...
What is the current status of trial NCT06409286?
This trial is currently not yet recruiting. The enrollment target is 17 participants. The study started on 2025-07. Estimated completion is 2025-12.
What interventions are being tested in trial NCT06409286?
The interventions under investigation include: Thermal Anisotropy Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT06409286?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.